rhinectomy is the surgical excision of part or all of the external nose and underlying structural cartilage, typically performed to achieve clear oncologic margins or remove necrotic tissue. It is fundamentally an ablative procedure, distinguishing it from rhinoplasty, which focuses on functional or cosmetic reconstruction, and septectomy, which only removes the internal nasal septum. The physiological mechanism involves the en bloc resection of cutaneous, cartilaginous, and occasionally bony tissues to halt the local spread of invasive malignancies or destructive infections. It is strictly a pathological/therapeutic intervention (e.g., for squamous cell carcinoma or mucormycosis) and never a physiological process. Clinically relevant subtypes include partial rhinectomy (removing the lower third/ala) and total rhinectomy (removing the entire external nose), often necessitating complex prosthetic or flap reconstruction. It is commonly confused with nasal polypectomy or turbinectomy, which remove internal mucosal overgrowths without sacrificing the structural framework of the nose.
The word entered English in the 1880s as rhinectomy (noun), borrowed from modern surgical Latin, constructed directly from Greek roots as surgical techniques for head and neck oncology advanced in the late 19th century. The root rhin- (“nose”) connects rhinectomy to the entire -rhin- FAMILY: rhinitis (inflammation of the nose), rhinorrhea (discharge from the nose), and rhinoplasty (molding/reshaping of the nose). The suffix -ectomy is highly productive in surgical terminology, appearing in dozens of ablative procedure names such as mastectomy, glossectomy, and maxillectomy.
🔀 ALIASES / ALTERNATE TERMS
Rhinectomized(adjectival form — used to describe the post-operative state or defect, e.g., “rhinectomized wound bed,” “rhinectomized patient”)
Nasal resection / Nose removal(lay and clinical terms; often used in patient education and oncology consent forms)
Partial rhinectomy(removal of a portion of the nose, such as the lower half, ala, or tip; preserves the nasal bridge and upper cartilages)
Total rhinectomy(complete removal of the external nose down to the level of the nasal bones and maxilla)
Subtotal rhinectomy(removal of the majority of the external nose, sparing only a small rim of tissue or the nasal root)
C30.0(Malignant neoplasm of nasal cavity; the most common primary oncologic indication requiring this procedure)
Z90.09(Acquired absence of other parts of head and neck; used to code the post-procedural status of a patient missing their nose)
B46.1(Rhinocerebral mucormycosis; an invasive fungal infection that may necessitate radical nasal debridement/rhinectomy)
Nasal cavity ablation(clinical descriptor synonym used in broader head and neck tumor board discussions)
Midfacial resection(broader anatomic subtype that may include rhinectomy along with maxillectomy or orbital exenteration for advanced tumors)
🔗 RELATED TERMS
rhinoplasty — the functional or cosmetic reconstruction and reshaping of the nose; the conceptual and surgical opposite of an ablative rhinectomy.
rhinitis — shares the rhin- root; inflammation of the nasal mucosa, a benign condition that does not require surgical excision.
maxillectomy — surgical removal of the maxilla; frequently performed concurrently with a total rhinectomy for advanced sinonasal malignancies that cross anatomical boundaries.
glossectomy — surgical removal of the tongue; another major head and neck ablative procedure sharing the same surgical principles of en bloc resection and flap reconstruction.
Surgical ablation — the physiological mechanism of removing diseased tissue to halt local or systemic spread; the foundational principle behind rhinectomy.
Reconstructive flap — tissue transferred from a donor site to rebuild the nose following rhinectomy; essential for restoring facial contour and separating the nasal and oral cavities.
C44.392 — Other specified malignant neoplasm of skin of right part of nose; a specific cutaneous indication (like squamous cell carcinoma) that may prompt a partial or total rhinectomy.
B46.1 — Rhinocerebral mucormycosis; an aggressive, angioinvasive fungal infection in immunocompromised patients that causes rapid tissue necrosis, often requiring emergent rhinectomy to save the patient’s life.
D14.0 — Benign neoplasm of middle ear, nasal cavity and accessory sinuses; while benign, locally aggressive tumors (like inverted papilloma) may occasionally require limited rhinectomy for complete excision.
Nasal prosthesis — a silicone or acrylic facial appliance used to restore the appearance of the nose in patients who are not candidates for surgical reconstruction following rhinectomy.
69990 — Microsurgical techniques, requiring use of operating microscope; an add-on CPT code frequently utilized during the free-flap reconstruction phase immediately following a rhinectomy.
CODING CORNER
🏥 ICD-10-CM CODES
Malignant Neoplasms of Nasal Cavity & Sinuses (Primary Oncologic Indications)
Code
Description
C30.0
Malignant neoplasm of nasal cavity
C31.0
Malignant neoplasm of maxillary sinus
C31.1
Malignant neoplasm of ethmoidal sinus
C44.392
Other specified malignant neoplasm of skin of right part of nose
C44.399
Other specified malignant neoplasm of skin of unspecified part of face
Acquired Absence & Post-Procedural Status (Follow-up & Aftercare)
Code
Description
Z90.09
Acquired absence of other parts of head and neck (includes acquired absence of nose)
Z48.810
Encounter for surgical aftercare following surgery on the sense organs
Z48.89
Encounter for other specified surgical aftercare (e.g., post-op flap checks)
Microsurgical techniques, requiring use of operating microscope (add-on code for microvascular anastomosis)
⚠️ Coding Note: When coding a rhinectomy, the primary ICD-10-CM code must reflect the underlying pathology (e.g., C30.0 for nasal cavity carcinoma or B46.1 for mucormycosis), not just a symptom like epistaxis or nasal obstruction. Because rhinectomy is an ablative procedure, do not unbundle inherent local tissue rearrangement into the primary excision code (30150 or 30160); however, complex pedicled flaps (15732), free tissue transfers (15758), and adjacent tissue transfers (14060) are separately reportable when performed for reconstruction. If the reconstructive phase is delayed and performed at a separate operative session during the global period, append modifier -58 (Staged or Related Procedure) to the reconstructive CPT code. For post-operative encounters where the patient presents for routine healing checks or prosthetic fitting after the global period has expired, transition to status codes like Z90.09 or aftercare codes like Z48.810 to ensure accurate risk adjustment and avoid implying active malignancy.